Size | Price | Stock | Qty |
---|---|---|---|
2g |
|
||
10g |
|
||
50g |
|
||
Other Sizes |
|
Purity: ≥98%
Zinc pyrithione (formerly known as OM-1563; AI3-62421; BCJ; BC-J OM1563; Biocut ZP, Finecide ZPT), an ingredient of commercial anti-dandruff shampoos, is an antifungal and antibacterial agent that disrupts membrane transport by blocking the proton pump. Zinc pyrithione is considered as a coordination complex of zinc structurally. The pyrithione ligands, which are formally monoanions, are chelated to Zn 2+ via oxygen and sulfur centers. In the crystalline state, zinc pyrithione exists as a centrosymmetric dimer, where each zinc is bonded to two sulfur and three oxygen centers.
ln Vitro |
Zinc pyrithione is regarded as a zinc coordination complex. Formally monoanions, the pyrithione ligands are chelated to Zn 2+ through the action of sulfur and oxygen centers. Zinc pyrithione is found in crystal form as a centrosymmetric dimer, with each zinc linked to two sulfur and three oxygen atoms. Nonetheless, the dimers split apart in solution due to the scission of a single Zn-O link. The half-maximal effect (K1/2) of zinc pyrithione (a dimer that is likely biologically active as a monomer) is approximately 0.3 mM, and it causes plasma membrane depolarization[1]. Zinc Pyrithione (10 nM-10 μM; 72 hours) dramatically causes AAVS1 cell death[2].
|
||
---|---|---|---|
ln Vivo |
|
||
Animal Protocol |
|
||
ADME/Pharmacokinetics |
Absorption, Distribution and Excretion
Twenty-six mature Yorkshire pigs were used in this study. Radiolabeled zinc pyrithione was applied /dermally/ for 8 hr either as a single dose (50,100, and 400 mg/kg) or as a 5 day repeated dose (100 mg/kg). Serial samples of blood, urine, and feces were taken after dosing. Radioassay of necropsy material, urine, blood, and feces showed recovery of 86.8-98.2% of applied radioactivity. Greater than 90% of recovery was obtained from washings of the application site. Urinary excretion was 3% in animals with intact skin. Levels of radioactivity in blood, urine, and feces returned to background by 48 hours post-application. Dermal Absorption Factor: 3%. ...Less than 1% of administered zinc pyrithione is absorebed /through the skin/. Metabolism of zinc ... 2-Pyridinethiol 1-oxide has been investigated in Yorkshire pigs after IV admin. Within 96 hr ... 56% of zinc salt ... was excreted in urine. After IV admin in rabbits (14)C disappeared from blood rapidly, within 6 hr, 75% was excreted into urine while concentration of (65)Zn remained relatively constant with only 0.5% excreted into urine. Tissue concentration of (65)Zn were about 10 times higher than (14)C. Eight hr after dermal application, 0.5% of (14)C was excreted into urine, and same amount was found in major organs of rabbit. Less than 0.002% of applied (65)Zn was found in urine and 0.008% was found in major organs. For more Absorption, Distribution and Excretion (Complete) data for Pyrithione zinc (7 total), please visit the HSDB record page. Metabolism / Metabolites Zinc pyridinethione was biotransformed in rabbits, rats, monkeys, and dogs after oral dosing into 2-pyridinethiol 1-oxide S-glucuronide and 2-pyridinethiol S-glucuronide. Orally admin in rat (14)C-labeled zinc pyrithione's major route of elimination from the body was urine, minor metabolite was 2-mercaptopyridine-N-oxide, & major were S-glucuronides of 2-mercaptopyridine-N-oxide. 2-(Methylsulfonyl)pyridine was identified, minor serum metabolites were 2-(methylthio) pyridine 1-oxide, 2-(methylthio)pyridine, & 2-(methylsulfinyl)pyridine 1-oxide. Zinc can enter the body through the lungs, skin, and gastrointestinal tract. Intestinal absorption of zinc is controlled by zinc carrier protein CRIP. Zinc also binds to metallothioneins, which help prevent absorption of excess zinc. Zinc is widely distributed and found in all tissues and tissues fluids, concentrating in the liver, gastrointestinal tract, kidney, skin, lung, brain, heart, and pancreas. In the bloodstream zinc is found bound to carbonic anhydrase in erythrocytes, as well as bound to albumin, _2-macroglobulin, and amino acids in the the plasma. Albumin and amino acid bound zinc can diffuse across tissue membranes. Zinc is excreted in the urine and faeces. (L49) |
||
Toxicity/Toxicokinetics |
Toxicity Summary
Anaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc. (L48, L49, A49) Toxicity Data LD50: 177 mg/kg (Oral, Rat) (L545) LD50: 100 mg/kg (Dermal, Rabbit) (L545) LC50: 140 mg/m3 over 4 hours (Inhalation, Rat) (L545) Interactions In mice infected with Staphylococcus aureus strain exhibiting resistance to penicillin, Omnadin Z when given in combination with penicillin g sodium incr the antibiotic effect considerably, combination had stimulating effect on the immune response. DMSO (dimethylsulfoxide) aided the percutaneous penetration of zinc pyrithione in comparison with water, as evidenced by earlier onset of toxic signs. Non-Human Toxicity Values LD50 Rat male oral 630 mg/kg /Technical grade zinc pyrithione/ LD50 Rat female oral 460 mg/kg /Technical grade zinc pyrithione/ LD50 Rat (female) oral 177 mg/kg LD50 Rat (male) oral 207 mg/kg For more Non-Human Toxicity Values (Complete) data for Pyrithione zinc (9 total), please visit the HSDB record page. |
||
References | |||
Additional Infomation |
Zinc pyrithione is a fine beige granules. (NTP, 1992)
Pyrithione Zinc is a coordination complex of the zinc ion and pyrithione, a derivative of the naturally occurring antibiotic aspergillic acid with antimicrobial, antifungal and anti-seborrheic effects. Although the exact mechanism of action remains to be fully elucidated, pyrithione zinc appears to interfere with the membrane transport of ions and metabolites, ultimately leading to a loss of metabolic control. In addition, this agent causes an influx of copper, leading to a reduction in the activity of iron-sulphur proteins resulting in growth inhibition. Zinc pyrithione is a chemical compound of zinc. It is used as an antifungal and antibacterial agent. Zinc is a metallic element with the atomic number 30. It is found in nature most often as the mineral sphalerite. Though excess zinc in harmful, in smaller amounts it is an essential element for life, as it is a cofactor for over 300 enzymes and is found in just as many transcription factors. (L48, L49, L76) See also: Pyrithione (has active moiety); Biotin; pyrithione zinc (component of); Pyrithione zinc; salicylic acid (component of) ... View More ... Therapeutic Uses Keratolytic Agents /Pyrithione zinc/ effectiveness in dandruff and seborrhea is purported to result from both /cytostatic and antifungal/ actions and ... residual adherence to the skin after shampoo and rinse. An international questionnaire completed by 722 dermatologists assessed the belief of tachyphylaxis incidence with pyrithione zinc (PTZ)-based shampoos, time course, occurrence relative to active ingredients, and effect of switching products. Two double-blind, randomized, clinical evaluations were conducted, 24- and 48-week studies, whereby a 1% PTZ shampoo, a 2% PTZ shampoo, or a matched placebo control shampoo was used by each subject for the duration of the study. Dermatologists assessed the adherent scalp flaking (scale of 0-10) at baseline and at specified intervals. 64% of responding dermatologists believed tachyphylaxis occurred with PTZ products, and most felt that tachyphylaxis occurred within 3 months of use. Evaluation of mean treatment responses vs. placebo and individual responses as a function of study duration showed a consistent benefit for all products at all time points; therefore, no evidence for tachyphylaxis was found (within 48 weeks of treatment) ... Dandruff results from at least three etiologic factors: Malassezia fungi, sebaceous secretions, and individual sensitivity ... Of the three etiologic factors implicated in dandruff, Malassezia, sebaceous triglycerides, and individual susceptibility, Malassezia are the easiest to control. Pyrithione zinc kills Malassezia and all other fungi, and is highly effective against the Malassezia species actually found on scalp. Reduction in fungi reduces free fatty acids, thereby reducing scalp flaking and itch. ... The efficacy and safety of ketoconazole (KET) 2% and zinc pyrithione (ZPT) 1% in shampoo formulations for the alleviation of severe dandruff and seborrheic dermatitis /were compared/. This open randomized, parallel-group trial began with a 2-week run-in phase during which subjects applied a neutral non-antidandruff shampoo. It was followed by a 4-week randomized treatment phase and a subsequent 4-week follow-up phase without treatment. Shampooing during the treatment period was carried out twice weekly for the KET group and at least twice weekly for the ZPT group in accordance with the label instructions. A total of 343 subjects were recruited to enter the trial. Of the 331 eligible volunteers, 171 were randomized to KET 2% and 160 to ZPT 1%. ... Beneficial effects were evidenced for both medicated shampoos, but the effect was significantly better for KET 2%, which achieved a 73% improvement in the total dandruff severity score compared with 67% for ZPT 1% at week 4 (p < 0.02). The recurrence rate of the disease was also significantly lower following KET 2% treatment than following ZPT 1% treatment ... Both formulations were well tolerated. Drug Warnings A patient had had stable psoriasis for 25 years and no any other skin disease. Within 20 days, she developed an aggravated scaly erythematous patch on the scalp, where /an antidandruff/ shampoo had been applied, and simultaneously developed pustular psoriasis on both forearms. Patch testing showed a relevant sensitization to zinc pyrithione, and ... symptomatic aggravation by provocation testing with zinc pyrithione shampoo /was observed/... A case of allergic contact dermatitis to a shampoo containing zinc pyrithione associated with an eruption of pustular psoriasis is reported. The patient had had stable psoriasis for 5 years, and never any other skin disease. Within 1 week she developed severe generalized pustular psoriasis with many lesions where the shampoo was applied. Treatment with cyclosporin, 200 to 300 mg daily, cleared the eruption within 4 weeks, except for psoriasis of the scalp. Extensive patch testing revealed a relevant sensitization to zinc pyrithione ... |
Molecular Formula |
C10H8N2O2S2ZN
|
|
---|---|---|
Molecular Weight |
317.7
|
|
Exact Mass |
315.931
|
|
CAS # |
13463-41-7
|
|
Related CAS # |
1121-31-9;
|
|
PubChem CID |
26041
|
|
Appearance |
White to off-white solid powder
|
|
Density |
1.782 g/cm3 (25ºC)
|
|
Boiling Point |
253.8ºC at 760 mmHg
|
|
Melting Point |
262ºC
|
|
Flash Point |
107.3ºC
|
|
Vapour Pressure |
0.00275mmHg at 25°C
|
|
LogP |
3.34
|
|
Hydrogen Bond Donor Count |
0
|
|
Hydrogen Bond Acceptor Count |
4
|
|
Rotatable Bond Count |
2
|
|
Heavy Atom Count |
17
|
|
Complexity |
183
|
|
Defined Atom Stereocenter Count |
0
|
|
InChi Key |
OTPSWLRZXRHDNX-UHFFFAOYSA-L
|
|
InChi Code |
InChI=1S/2C5H5NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4,8H;/q;;+2/p-2
|
|
Chemical Name |
zinc;1-oxidopyridin-1-ium-2-thiolate
|
|
Synonyms |
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
|||
---|---|---|---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.87 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.1476 mL | 15.7381 mL | 31.4762 mL | |
5 mM | 0.6295 mL | 3.1476 mL | 6.2952 mL | |
10 mM | 0.3148 mL | 1.5738 mL | 3.1476 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
NCT06242743 | RECRUITING | Other:Scalpel blade needles Other:standard blade needles |
Anesthesia,Local | Hams Hamed Abdelrahman | 2024-01-01 | Not Applicable |
NCT05228288 | RECRUITING | Procedure:Conventional direct laryngoscopy (CDL) |
Endotracheal Intubation | Wuerzburg University Hospital | 2022-03-28 | Not Applicable |
NCT06322719 | RECRUITING | Device:Hyperangulated blade videolaryngoscope Device:Macintosh blade videolaryngoscope |
Acute Respiratory Failure Intubation Intubation;Difficult or Failed |
Hospital Clinico Universitario de Santiago |
2024-05-01 | Not Applicable |
NCT06307223 | COMPLETED | Drug:30% supramolecular salicylic acid Drug:supramolecular active zinc |
Malassezia Folliculitis | Second Affiliated Hospital of Xi'an Jiaotong University |
2022-06-07 | Phase 4 |
NCT05599451 | COMPLETED | Other: THS Blade device Other: THS Induction Mono device Other: THS Induction Mid device Other: CIG |
Smoking Tobacco Smoking Tobacco Use |
Philip Morris Products S.A. | 2022-11-16 | Not Applicable |